26.98
0.30 (1.12%)
| Penutupan Terdahulu | 26.68 |
| Buka | 26.50 |
| Jumlah Dagangan | 167,800 |
| Purata Dagangan (3B) | 543,029 |
| Modal Pasaran | 11,802,160,128 |
| Harga / Pendapatan (P/E TTM) | 14.58 |
| Harga / Pendapatan (P/E Ke hadapan) | 14.66 |
| Harga / Jualan (P/S) | 2.24 |
| Harga / Buku (P/B) | 1.00 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 14 Aug 2025 - 18 Aug 2025 |
| Hasil Dividen (DY TTM) | 3.41% |
| Margin Keuntungan | 15.58% |
| Margin Operasi (TTM) | 15.74% |
| EPS Cair (TTM) | 1.97 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -4.30% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -7.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.60% |
| Nisbah Semasa (MRQ) | 4.25 |
| Aliran Tunai Operasi (OCF TTM) | 658.48 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 247.88 M |
| Pulangan Atas Aset (ROA TTM) | 3.22% |
| Pulangan Atas Ekuiti (ROE TTM) | 6.09% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (HK) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | HAOHAI BIOTEC | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -1.5 |
| Purata | -0.88 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| HAOHAI BIOTEC | 12 B | 3.41% | 14.58 | 1.00 |
| 3SBIO | 67 B | 0.82% | 27.19 | 4.02 |
| KEYMED BIO-B | 19 B | - | - | 4.95 |
| ASCLETIS-B | 14 B | - | - | 6.56 |
| AKESO | 111 B | - | - | 15.36 |
| PHARMARON | 56 B | 0.92% | 22.04 | 2.34 |
|
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Value |
| % Dimiliki oleh Orang Dalam | 0.07% |
| % Dimiliki oleh Institusi | 20.16% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |